APOE ɛ2 and ɛ4 effects on cognitive decline in the oldest old (90+)

A new study from the LifeAfter90 cohort examined how APOE genetic variants—the most important genetic risk factors for Alzheimer's disease—affect cognitive decline in the oldest old. While APOE ɛ4 strongly predicts dementia risk in younger populations, its effects may differ in those who survive past 90. Conversely, APOE ɛ2 is generally protective. This longitudinal research tracked cognitive changes in nonagenarians to determine whether these genetic effects persist, diminish, or change in extreme old age. Understanding APOE's role in exceptional longevity matters because people reaching 90+ represent a select survivor population who may have compensatory mechanisms. The findings could reveal why some ɛ4 carriers avoid dementia despite genetic risk, and whether ɛ2's protective effects continue benefiting the oldest old. This has practical implications for predicting cognitive trajectories in an aging population and for understanding what distinguishes successful cognitive aging from typical decline—insights that could inform interventions for maintaining brain health into very late life.